Yin Xin Hua, Yan Liang, Yang Ming, Zhang Ke, He Bao Rong, Liu Zhong Kai, Hao Ding Jun
Department of Spine Surgery, Hong Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
Medicine (Baltimore). 2018 Dec;97(51):e13822. doi: 10.1097/MD.0000000000013822.
To investigate the clinical efficacy of surgical treatment for thoracic spinal tuberculosis with kyphosis deformity via posterolateral debridement, fusion, posterior instrumentation and local continuous chemotherapy. A total of 25 patients with thoracic tuberculosis received surgery by posterolateral decompression, fusion, posterior instrumentation, and postural drainage with local continuous chemotherapy between June 2009 and October 2011. The clinical outcomes was evaluated using statistical analysis about deformity correction, bone fusion, neurologic status, and the visual analog score (VAS) and erythrocyte sedimentation rate (ESR). All of 25 patients were followed up for 39.0 ± 10.7 months (range, 24-60 months) postoperatively. There was no recurrence of tuberculosis, breakage and looseness of internal fixation. Bony fusion was achieved in all cases with 6.7 ± 1.9 months. The values of ESR recovered to normal within 6 months postoperatively. All patients with neurological deficit had significant improvement at the final follow-up. The average preoperative Cobb angles were significantly decreased to 12.2 ± 2.9° (range, 8-17°) postoperatively, and at final follow-up were 12.9 ± 2.7°. Our results showed that single-stage posterolateral debridement fusion, posterior instrumentation and local continuous chemotherapy can be expected to yield satisfactory clinical and radiographic outcomes in patients with thoracic spinal tuberculosis.
探讨经后外侧清创、融合、后路内固定及局部持续化疗治疗胸段脊柱结核伴后凸畸形的临床疗效。2009年6月至2011年10月期间,共有25例胸段脊柱结核患者接受了后外侧减压、融合、后路内固定及体位引流并局部持续化疗的手术。通过对畸形矫正、骨融合、神经功能状态、视觉模拟评分(VAS)和红细胞沉降率(ESR)进行统计分析来评估临床疗效。所有25例患者术后随访39.0±10.7个月(范围24 - 60个月)。无结核复发、内固定断裂及松动情况。所有病例均在6.7±1.9个月实现了骨融合。ESR值在术后6个月内恢复正常。所有神经功能缺损患者在末次随访时均有显著改善。术前平均Cobb角术后显著降至12.2±2.9°(范围8 - 17°),末次随访时为12.9±2.7°。我们的结果表明,一期后外侧清创融合、后路内固定及局部持续化疗有望为胸段脊柱结核患者带来满意的临床和影像学疗效。